An Indian-run pharmaceutical plant operated by Kusum Group in Ukraine’s Sumy region was largely destroyed in Russian drone attacks, according to an NDTV report published on October 4, 2026. The attack killed one person and left several others injured, with officials warning that the casualty count could change as the situation develops. What happened at the Kusum Group pharma plant in Ukraine?A major pharmaceutical facility belonging to India’s Kusum Group came under attack by Russian drones in Ukraine’s Sumy region. The main structure of the plant was reported to be mostly destroyed following the strikes. Visuals from the site showed a large plume of smoke rising from the area where the drones struck. Officials said one person was killed and several others were injured, while noting that the number of casualties could change as authorities assess the damage. Where is the Indian-run pharmaceutical plant located?The affected facility is located in Sumy, Ukraine, where Kusum operates a pharmaceutical production site. The company’s official website lists its Sumy plant at 54 Skriabina Street, Sumy Region, 40000. Kusum describes itself as a Ukrainian pharmaceutical company with a production facility in Sumy that operates under international Good Manufacturing Practice (GMP) standards. The company says its operations include pharmaceutical manufacturing and quality-control infrastructure.How serious is the damage from the drone attack?The attack has caused extensive damage to the pharmaceutical facility, with the main plant structure described as mostly destroyed. The incident comes amid an intensifying wave of Russian drone and missile attacks across Ukraine. The latest attack is part of a broader escalation in aerial strikes. Ukraine has reported increasingly frequent drone attacks, including the use of faster jet-powered drones that have created additional challenges for Ukrainian air-defence systems. What happens next after the attack?Authorities are expected to assess the full extent of the destruction and determine the number of casualties and injuries as emergency operations continue. The immediate priority remains rescue and damage assessment at the affected facility. The destruction could also affect pharmaceutical manufacturing and operations at the Sumy facility. However, the full financial impact and the company's plans for restoring production have not yet been officially detailed in the latest reports.The attack comes as Russia continues its intensified aerial campaign against Ukraine, with strikes reported against infrastructure and other facilities in several parts of the country
